---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-029768"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2025-09-24T23:59:59+00:00"
generated_at: "2026-05-17T05:51:13.677773+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BioCardia regains Nasdaq compliance after raising $7.35M through equity offerings

## Summary
- Raised net proceeds of $0.7M (Apr), $0.5M (Jun), $5.1M (Sep public offer), and $1.0M from ATM sales (Apr–Sep 2025).
- Believes stockholders' equity now exceeds the $2.5M minimum for continued listing under Nasdaq Rule 5550(b)(1).
- Earlier Nasdaq extension to Sep 29, 2025; compliance will be monitored at next periodic report.
- Warrants exercisable earlier of 2030 or PMDA approval of CardiAMP Cell Therapy System.

## SEC filing metadata
- accession: 0001437749-25-029768
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2025-09-24T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774925029768/0001437749-25-029768-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774925029768/bcda20250923_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-029768
- JSON: https://secwatch.observer/filing/0001437749-25-029768.json
- Plain text: https://secwatch.observer/filing/0001437749-25-029768.txt

## Key facts
- Listing & Compliance Notices
  BioCardia, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: April 1, 2025, BioCardia, Inc. (the “Company,” “we,” “us” and “our”) received a notification letter (the “Notice”) from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its amount of stockholders’ equity had fallen below the $2,500,000 required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1). As noted in the Original 8-K, the Company had until May 16, 2025 to provide Nasdaq with a specific plan to achieve and sustain compliance. The Company submitted its plan to regain compliance on May 15, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/925741/000143774925029768/0001437749-25-029768-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.